CHURCH AND DWIGHT INC (CHD)
Sector: Consumer Staples
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Consumer Staples
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CHD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CHD | Retired Executive Advisor for privateequity firms and former CEO,OraPharma, Inc. | [] | ["Governance,NominatingandCorporateResponsibility","Executive"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| XRAY | Director; Chair of the Science and Technology Committee | 61 | ["over 35 years of experience in the healthcare industry","executive advisor to private equity firms","Chief Executive Officer of OraPharma","managed a multi-billion portfolio at Johnson & Johnson as President of Janssen Pharmaceuticals","member of company management boards for over 10 years","experience in research and development, new product development, sales, and marketing","B.S. degree in Biology","M.S. degree in Physiology","Large Company Experience","DENTSPLY SIRONA History and Industry","Medical Device or Industry Experience","International Business Experience","Financial Literacy","Public Company Governance Experience"] | ["Science and Technology Committee","Compensation & Human Capital Committee"] | 2026 |
| AMRX | Chair; Director | 54 | ["CEO, General Management, Commercial", "Corporate Development, Business Development, Mergers & Acquisitions", "Investment, Venture Capital", "R&D, Scientific"] | ["audit", "governance"] | 2019 |
Biography sourced from the proxy statement filing.
Retired Executive Advisor for private equity firms and former CEO, OraPharma, Inc.